<DOC>
	<DOCNO>NCT00887783</DOCNO>
	<brief_summary>This study open label randomize multi-centre phase II trial patient inoperable locally advanced stage IIB-IIIB Non Small Cell Lung Cancer fulfil general criterion curatively intend irradiation . The treatment plan consist two course induction chemotherapy follow concomitant therapy chemo-radiotherapy 3 week day 1 last induction chemotherapy give . The patient include study complete induction chemotherapy . Randomization take place acceptable dose plan obtain .</brief_summary>
	<brief_title>Navelbine And Radiotherapy Locally Advanced Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Age ≥18 year Patients histologically cytologically document diagnosis locally advance NSCLC stage IIB IIIB without pleural effusion Performance status 01 ECOG scale Weight loss ≤10 % last 6 month Adequate lung function measure FEV1 ≥1.0 Neutrophile count ≥1.5 x 109/L platelet count ≥100 x 109/L Serum bilirubin ≤1.5 upper limit normal ( ULN ) ALAT ≤2 x ULN Able comply study followup procedure Patients reproductive potential must use effective contraception Written ( sign ) inform consent participate study Any unstable systemic disease ( include active infection , unstable angina , congestive heart failure , severe hepatic , renal , metabolic disease ) Any active malignancy within 5 year ( except adequately treat carcinoma situ cervix basal squamous cell skin cancer ) Prior chemotherapy lung cancer , include neo adjuvant chemotherapy Inability take oral medication , requirement intravenous alimentation Active peptic ulcer disease Nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Induction chemotherapy</keyword>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>Randomized phase II study</keyword>
	<keyword>Navelbine Oral ( R )</keyword>
	<keyword>3D-conformal radiotherapy</keyword>
	<keyword>Chemo-radiotherapy</keyword>
	<keyword>Local-regionally advanced non-small cell lung cancer</keyword>
</DOC>